Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia-Reference-Cited by-同舟云学术

Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia

Published:2012-06-13 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gurion Ronit¹,Belnik-Plitman Yulia¹,Gafter-Gvili Anat²,Paul Mical³,Vidal Liat²,Ben-Bassat Isaac⁴,Shpilberg Ofer¹,Raanani Pia¹

Affiliation:

1. Beilinson Hospital, Rabin Medical Center; Institute of Hematology, Davidoff Center; 39 Jabotinski Street Petah Tikva Israel 49100

2. Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100

3. Sackler Faculty of Medicine; Infectious Diseases Unit; Tel Aviv University Tel Aviv Israel 49100

4. Tel Aviv University; Sackler School of Medicine; Tel Aviv Israel

Publisher

Wiley

Subject

Pharmacology (medical)

Reference123 articles.

1. Use of glycosylated recombinant human G-CSF during and/or after induction chemotherapy in elderly patients with acute myeloid leukemia: final results of AML-13, a randomized phase III study of the EORTC and GIMEMA Leukemia Groups;Amadori;Blood,2003

2. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study;Amadori;Blood,2005

3. Amadori SA Suciu S Jehn U Thomas X Marie JP Muus P Lenograstim combined with induction chemotherapy in elderly patients with AML: results of a randomized phase III trial (AML-13) of the EORTC Leukemia Group and the GIMEMA Cooperative Group European Hematology Association Website (http://www .ehaweb .org) 2003

4. Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: results of a randomized multicenter phase III trial;Beksac;Leukemia Research,2011

5. Randomized clinical study comparing aggressive chemotherapy with or without G-CSF support for high risk myelodysplastic syndromes or secondary acute myeloid leukemia evolving from MDS;Bernasconi;British Journal of Haematology,1998

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Prophylactic Post-Chemotherapy G-CSF on the Relapse Rates in Patients with Acute Myeloid Leukemia: A Meta-Analysis;Cancer Investigation;2024-06-26

2. JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML);International Journal of Hematology;2024-03-14

3. Impact of rhG-CSF on Clinical Efficacy and Immune Cell Subsets after Initial Induction Chemotherapy in AML;Clinical Laboratory;2023

4. Frontline Management of Acute Myeloid Leukaemia Eligible for Intensive Chemotherapy;Pathogenesis and Treatment of Leukemia;2023

5. Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortium;Expert Review of Anticancer Therapy;2022-10-28